The Acute Opioid Overdosage drugs in development market research report provides comprehensive information on the therapeutics under development for Acute Opioid Overdosage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Acute Opioid Overdosage. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Acute Opioid Overdosage and features dormant and discontinued products.
GlobalData tracks 11 drugs in development for Acute Opioid Overdosage by ten companies/universities/institutes. The top development phase for Acute Opioid Overdosage is preclinical with five drugs in that stage. The Acute Opioid Overdosage pipeline has ten drugs in development by companies and one by universities/ institutes. Some of the companies in the Acute Opioid Overdosage pipeline products market are: Orexo, Elysium Therapeutics and Klaria Pharma Holding.
The key targets in the Acute Opioid Overdosage pipeline products market include Mu Type Opioid Receptor, Kappa Type Opioid Receptor, and Delta Type Opioid Receptor.
The key mechanisms of action in the Acute Opioid Overdosage pipeline product include Mu Type Opioid Receptor Antagonist with nine drugs in Filing rejected/Withdrawn. The Acute Opioid Overdosage pipeline products include six routes of administration with the top ROA being Subcutaneous and one key molecule types in the Acute Opioid Overdosage pipeline products market including Small Molecule.
Acute Opioid Overdosage overview
Opioids are common treatment strategy for treating pain. Drug abuse is commonly seen with opioids as these are habit forming drugs or by misuse. Opioid overdose occurs when opioid medications are taken in larger quantities irrespective of the prescribed amount. Overdosage stimulates the opiate pathway leading to decreased respiratory function and death. Common causes are prescription error, misuse that can be intentional or unintentional. To overcome these ill effects dosage monitoring is practiced with opiates. Respiratory depression, apnea, miosis, drowsiness, confusion and neuro complications are seen. Physical examination of eye lids, respiratory rate, and lab examinations of presence of opioid in blood from the time of ingestion. Antidote naloxone is a common therapeutic approach in patients diagnosed with opiate overdose. Respiratory support with oxygen and removal of opioid toxins from blood and prevention of infections.
For a complete picture of Acute Opioid Overdosage’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
